Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.395
Delayed Data
As of Aug 28
 +0.005 / +1.28%
Today’s Change
0.34
Today|||52-Week Range
3.98
-75.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

--
Operating ActivitiesNet Income / Starting Line-12.9M-20.9M-8.8M--
 
 
 
 
Depreciation147.0K99.0K87.0K--
 
 
 
 
Total Other Cash Flow7.1M14.2M1.8M--
 
 
 
 
Funds From Operations-5.6M-6.6M-6.9M--
 
 
 
 
Funds From/For Other Operating Expenses-525.0K-286.0K881.0K--
 
 
 
 
Net Cash Flow - Operating Activities-5.1M-6.3M-7.8M--
 
 
 
 
 
InvestingIncrease In Investments0.00-9.0M-5.0M--
 
 
 
Decrease In Investments0.006.0M8.0M--
 
 
 
Capital Expenditures-15.0K-78.0K-95.0K--
 
 
 
 
Fixed Asset Disposal33.0K0.0012.0K--
 
 
 
Other Investing - Uses-2.0K-18.0K0.00--
 
 
 
Other Investing - Sources0.003.0K0.00--
 
 
Net Cash Flow Investing16.0K-3.1M2.9M--
 
 
 
 
 
FinancingShort Term Borrowings0.00-5.0K0.00--
 
 
Long Term Borrowings500.0K0.000.00--
 
 
Long Term Debt Reduction-29.0K0.000.00--
 
 
Net Proceeds Stock Sale9.2M15.7M1.9M--
 
 
 
 
Common Preferred Redeemed0.00-12.0K0.00--
 
 
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing9.7M15.7M1.9M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.00----
 
Net Change In Cash4.6M6.3M-2.9M--